High Financial Hardship among Patients with Advanced Ovarian Cancer

References

• Abbott, D. E., Voils, C. L., Fisher, D. A., Greenberg, C. C., & Safdar, N. (2017). Socioeconomic disparities, financial toxicity, and opportunities for enhanced system efficiencies for patients with cancer. Journal of Surgical Oncology, 115(3), 250–256. doi:10.1002/jso.24528
   PubMed Web of Science ®Google Scholar
• Albright, B. B., Nitecki, R., Chino, F., Chino, J. P., Havrilesky, L. J., Aviki, E. M., & Moss, H. A. (2022). Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer patients in the United States. American Journal of Obstetrics and Gynecology, 226(3), 384.e381–384.e313. doi:10.1016/j.ajog.2021.09.034
   Web of Science ®Google Scholar
• Altice, C. K., Banegas, M. P., Tucker-Seeley, R. D., & Yabroff, K. R. (2016). Financial hardships experienced by cancer survivors: A systematic review. Journal of the National Cancer Institute, 109(2), djw205. doi:10.1093/jnci/djw205
   PubMedGoogle Scholar
• American Cancer Society. (2022). Key statistics for ovarian cancer. Retrieved from https://www.cancer.org/cancer/ovarian-cancer/about/key-statistics.html#:∼:text=Ovarian%20cancer%20ranks%20fifth%20in,is%20about%201%20in%20108.
   Google Scholar
• Aviki, E. M., Thom, B., Braxton, K., Chi, A. J., Manning-Geist, B., Chino, F., … Gany, F. M. (2022). Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment. Support Care Cancer, 30(3), 2713–2721. doi:10.1007/s00520-021-06697-6
   PubMed Web of Science ®Google Scholar
• Aviki, E., Manning-Geist, B., Sokolowski, S., Newman, T., Blinder, V., Chino, F., … Abu-Rustum, N. (2021). Risk factors for financial toxicity in gynecologic cancer patients. American Journal of Obstetrics and Gynecology, 226, 817.e1–817.e9. doi:10.1016/j.ajog.2021.12.012
   PubMed Web of Science ®Google Scholar
• Bouberhan, S., Shea, M., Kennedy, A., Erlinger, A., Stack-Dunnbier, H., Buss, M. K., … Esselen, K. M. (2019). Financial toxicity in gynecologic oncology. Gynecologic Oncology, 154(1), 8–12. doi:10.1016/j.ygyno.2019.04.003
   PubMed Web of Science ®Google Scholar
• Bruce, C., Gearing, M. E., DeMatteis, J., Levin, K., Mulcahy, T., Newsome, J., & Wivagg, J. (2022). Financial vulnerability and the impact of COVID-19 on American households. PLOS One. 17(1), e0262301. doi:10.1371/journal.pone.0262301
   PubMed Web of Science ®Google Scholar
• Carrera, P. M., & Kantarjian, H. M. (2018). The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment. Cancer Journal for Clinicians, 68(2), 153–165. doi:10.3322/caac.21443
   PubMed Web of Science ®Google Scholar
• Chebli, P., Lemus, J., Avila, C., Peña, K., Mariscal, B., Merlos, S., … Molina, Y. (2020). Multilevel determinants of financial toxicity in breast cancer care: Perspectives of healthcare professionals and Latina survivors. Supportive Care in Cancer, 28(7), 3179–3188. doi:10.1007/s00520-019-05119-y
   PubMed Web of Science ®Google Scholar
• Conley, C. C., Buras, A. L., McIntyre, M., Santiago-Datil, W., English, D., Wenham, R. M., & Vadaparampil, S. T. (2023). It doesn’t really apply to what I'm going through: A mixed-methods study of barriers to palliative care among patients with advanced ovarian cancer. Supportive Care in Cancer, 31(7), 397. doi:10.1007/s00520-023-07832-1
   PubMed Web of Science ®Google Scholar
• Cutillo, A., O’Hea, E., Person, S., Lessard, D., Harralson, T., & Boudreaux, E. (2017). The distress thermometer: Cutoff points and clinical use. Oncology Nursing Forum, 44(3), 329–336. doi:10.1188/17.ONF.329-336
   PubMed Web of Science ®Google Scholar
• de Boer, A. G., Taskila, T., Ojajärvi, A., van Dijk, F. J., & Verbeek, J. H. (2009). Cancer survivors and unemployment: A meta-analysis and meta-regression. JAMA, 301(7), 753–762. doi:10.1001/jama.2009.187
   PubMed Web of Science ®Google Scholar
• de Souza, J. A., & Wong, Y.-N. (2013). Financial distress in cancer patients. Journal of Medicine and the Person, 11(2), 73–77. doi:10.1007/s12682-013-0152-3
   Google Scholar
• De Souza, J. A., Wroblewski, K., Proussaloglou, E., Nicholson, L., Hantel, A., & Wang, Y. (2017). Validation of a financial toxicity (FT) grading system. Journal of Clinical Oncology, 35(15 suppl), 6615–6615. doi:10.1200/JCO.2017.35.15_suppl.6615
   Google Scholar
• Esselen, K. M., Gompers, A., Hacker, M. R., Bouberhan, S., Shea, M., Summerlin, S. S., … Liang, M. I. (2021). Evaluating meaningful levels of financial toxicity in gynecologic cancers. International Journal of Gynecologic Cancer, 31(6), 801–806. doi:10.1136/ijgc-2021-002475
   PubMed Web of Science ®Google Scholar
• Goldman, D. P., Joyce, G. F., & Zheng, Y. (2007). Prescription drug cost sharing: Associations with medication and medical utilization and spending and health. JAMA, 298(1), 61–69. doi:10.1001/jama.298.1.61
   PubMed Web of Science ®Google Scholar
• Gordon, L. G., Merollini, K. M. D., Lowe, A., & Chan, R. J. (2017). A systematic review of financial toxicity among cancer survivors: We can’t pay the co-pay. Patient, 10(3), 295–309. doi:10.1007/s40271-016-0204-x
   PubMedGoogle Scholar
• Guy, G. P., Ekwueme, D., Yabroff, K., Dowling, C., Li, C., Rodriguez, J., de Moor, J., … Virgo, K. (2013). Economic burden of cancer survivorship among adults in the United States. Journal of Clinical Oncology, 31(30), 3749–3757. doi:10.1200/jco.2013.49.1241
   PubMed Web of Science ®Google Scholar
• Liang, M. I., Pisu, M., Summerlin, S. S., Boitano, T. K. L., Blanchard, C. T., Bhatia, S., & Huh, W. K. (2020). Extensive financial hardship among gynecologic cancer patients starting a new line of therapy. Gynecologic Oncology, 156(2), 271–277. doi:10.1016/j.ygyno.2019.11.022
   PubMed Web of Science ®Google Scholar
• Liang, M. I., Simons, J. L., Herbey, I. I., Wall, J. A., Rucker, L. R., Ivankova, N. V., … Pisu, M. (2022). Navigating job and cancer demands during treatment: A qualitative study of ovarian cancer patients. Gynecologic Oncology, 166(3), 481–486. doi:10.1016/j.ygyno.2022.07.021
   PubMed Web of Science ®Google Scholar
• McGarvey, N., Gitlin, M., Fadli, E., & Chung, K. C. (2022). Increased healthcare costs by later stage cancer diagnosis. BMC Health Services Research, 22(1), 1155. doi:10.1186/s12913-022-08457-6
   PubMed Web of Science ®Google Scholar
• Mei, S., Chelmow, D., Gecsi, K., Barkley, J., Barrows, E., Brooks, R., … Burke, W. (2023). Health disparities in ovarian cancer: Report from the Ovarian Cancer Evidence Review Conference. Obstetrics & Gynecology, 142(1), 196–210. doi:10.1097/aog.0000000000005210
   PubMed Web of Science ®Google Scholar
• Mols, F., Tomalin, B., & Pearce, A. (2020). Financial toxicity and employment status in cancer survivors. A systematic literature review. Supportive Care in Cáncer, 28(12), 5693–5708. doi:10.1007/s00520-020-05719-z
   PubMed Web of Science ®Google Scholar
• Naora, H., & Montell, D. J. (2005). Ovarian cancer metastasis: Integrating insights from disparate model organisms. Nature Reviews Cancer, 5(5), 355–366. doi:10.1038/nrc1611
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. (2021). Cancer Stat facts: Ovarian cancer. SEER. https://seer.cancer.gov/statfacts/html/ovary.html.
   Google Scholar
• National Cancer Institute. (2022). Financial burden of cancer care. Retrieved from https://progressreport.cancer.gov/after/economic_burden
   Google Scholar
• Ng, M. S. N., Choi, K. C., Chan, D. N. S., Wong, C. L., Xing, W., Ho, P. S., … So, W. K. W. (2021). Identifying a cut-off score for the COST measure to indicate high financial toxicity and low quality of life among cancer patients. Support Care Cancer, 29(10), 6109–6117. doi:10.1007/s00520-020-05962-4
   PubMed Web of Science ®Google Scholar
• Palmer, J. D., Patel, T. T., Eldredge-Hindy, H., Keith, S. W., Patel, T., Malatesta, T., … Fisher, S. A. (2018). Patients undergoing radiation therapy are at risk of financial toxicity: A patient-based prospective survey study. International Journal of Radiation Oncology Biology Physics. 101(2), 299–305. doi:10.1016/j.ijrobp.2018.03.014
   PubMed Web of Science ®Google Scholar
• Pearce, A., Tomalin, B., Kaambwa, B., Horevoorts, N., Duijts, S., Mols, F., … Koczwara, B. (2019). Financial toxicity is more than costs of care: The relationship between employment and financial toxicity in long-term cancer survivors. Journal of Cancer Survivorship, 13(1), 10–20. doi:10.1007/s11764-018-0723-7
   PubMed Web of Science ®Google Scholar
• Popescu, R. A., Schäfer, R., Califano, R., Eckert, R., Coleman, R., Douillard, J. Y., … Piccart, M. (2014). The current and future role of the medical oncologist in the professional care for cancer patients: A position paper by the European Society for Medical Oncology (ESMO). Annals of Oncology, 25(1), 9–15. doi:10.1093/annonc/mdt522
   PubMed Web of Science ®Google Scholar
• Præstegaard, C., Kjaer, S. K., Nielsen, T. S., Jensen, S. M., Webb, P. M., Nagle, C. M., … Doherty, J. A. (2016). The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. Cancer Epidemiology, 41, 71–79. doi:10.1016/j.canep.2016.01.012
   PubMed Web of Science ®Google Scholar
• Sharp, L., & Timmons, A. (2016). Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors. Supportive Care in Cancer, 24(2), 699–709. doi:10.1007/s00520-015-2832-4
   PubMed Web of Science ®Google Scholar
• Smith, G. L., Banegas, M. P., Acquati, C., Chang, S., Chino, F., Conti, R. M., … Yabroff, K. R. (2022). Navigating financial toxicity in patients with cancer: A multidisciplinary management approach. Cancer Journal for Clinicians, 72(5), 437–453. doi:10.3322/caac.21730
   PubMed Web of Science ®Google Scholar
• Swiecki-Sikora, A. L., Craig, A. D., & Chu, C. S. (2022). Financial toxicity in ovarian cancer. International Journal of Gynecologic Cancer, 32(11), 1450–1454. doi:10.1136/ijgc-2022-003594
   Web of Science ®Google Scholar
• Tefferi, A., Kantarjian, H., Rajkumar, S. V., Baker, L. H., Abkowitz, J. L., Adamson, J. W., … LeMaistre, C. A. (2015). In support of a patient-driven initiative and petition to lower the high price of cancer drugs. Mayo Clinic Proceedings, 90(8), 996–1000. doi:10.1016/j.mayocp.2015.06.001
   PubMed Web of Science ®Google Scholar
• Tran, G., & Zafar, S. Y. (2018). Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Annals of Translational Medicine, 6(9), 166. doi:10.21037/atm.2018.03.28
   PubMed Web of Science ®Google Scholar
• Whitney, R. L., Bell, J. F., Reed, S. C., Lash, R., Bold, R. J., Kim, K. K., … Joseph, J. G. (2016). Predictors of financial difficulties and work modifications among cancer survivors in the United States. Journal of Cancer Survivorship, 10(2), 241–250. doi:10.1007/s11764-015-0470-y
   PubMed Web of Science ®Google Scholar
• Zafar, S. Y., Peppercorn, J. M., Schrag, D., Taylor, D. H., Goetzinger, A. M., Zhong, X., & Abernethy, A. P. (2013). The financial toxicity of cancer treatment: A pilot study assessing out‐of‐pocket expenses and the insured cancer patient’s experience. The Oncologist, 18(4), 381–390. doi:10.1634/theoncologist.2012-0279
   PubMed Web of Science ®Google Scholar
• Zeybek, B., Webster, E., Pogosian, N., Tymon-Rosario, J., Balch, A., Altwerger, G., … Andikyan, V. (2021). Financial toxicity in patients with gynecologic malignancies: a cross sectional study. Journal of Gynecologic Oncology, 32(6), e87. doi:10.3802/jgo.2021.32.e87
   PubMed Web of Science ®Google Scholar